Age-dependent vulnerability of cyclosporine-associated encephalopathy in children

Li Wen Chen; Jiann Shiuh Chen; Yi Fang Tu; Shan Tair Wang; Lan Wan Wang; Yi Shan Tsai; Chao Ching Huang

doi:10.1016/j.ejpn.2015.02.003

Age-dependent vulnerability of cyclosporine-associated encephalopathy in children

Li Wen Chen, Jiann Shiuh Chen, Yi Fang Tu, Shan Tair Wang, Lan Wan Wang, Yi Shan Tsai, Chao Ching Huang

Research output: Contribution to journal › Article

5 Citations (Scopus)

Abstract

Introduction Cyclosporine (CsA) is an immunosuppressant known for its neurotoxicity, which presents with acute encephalopathy and seizures in the most severe form. However, whether there is age-related neurological susceptibility in pediatric population is poorly defined. The study aims to examine the vulnerability of CsA neurotoxicity among different age groups of pediatric patients in terms of occurrence rate, acute presentations, long-term outcomes, and neuroimaging findings. Methods Pediatric patients (age

Original language	English
Pages (from-to)	464-471
Number of pages	8
Journal	European Journal of Paediatric Neurology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/j.ejpn.2015.02.003
Publication status	Published - Jul 1 2015

Fingerprint

Keywords

Age factors
Child
Cyclosporine
Neurotoxicity syndromes
Seizures
Status epilepticus

ASJC Scopus subject areas

Clinical Neurology
Pediatrics, Perinatology, and Child Health

Cite this

Chen, L. W., Chen, J. S., Tu, Y. F., Wang, S. T., Wang, L. W., Tsai, Y. S., & Huang, C. C. (2015). Age-dependent vulnerability of cyclosporine-associated encephalopathy in children. European Journal of Paediatric Neurology, 19(4), 464-471. https://doi.org/10.1016/j.ejpn.2015.02.003

@article{e0ce77e6d7e4402ba8b5d65a34d8b12c,

title = "Age-dependent vulnerability of cyclosporine-associated encephalopathy in children",

abstract = "Introduction Cyclosporine (CsA) is an immunosuppressant known for its neurotoxicity, which presents with acute encephalopathy and seizures in the most severe form. However, whether there is age-related neurological susceptibility in pediatric population is poorly defined. The study aims to examine the vulnerability of CsA neurotoxicity among different age groups of pediatric patients in terms of occurrence rate, acute presentations, long-term outcomes, and neuroimaging findings. Methods Pediatric patients (age ",

keywords = "Age factors, Child, Cyclosporine, Neurotoxicity syndromes, Seizures, Status epilepticus",

author = "Chen, {Li Wen} and Chen, {Jiann Shiuh} and Tu, {Yi Fang} and Wang, {Shan Tair} and Wang, {Lan Wan} and Tsai, {Yi Shan} and Huang, {Chao Ching}",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/j.ejpn.2015.02.003",

language = "English",

volume = "19",

pages = "464--471",

journal = "European Journal of Paediatric Neurology",

issn = "1090-3798",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Age-dependent vulnerability of cyclosporine-associated encephalopathy in children

AU - Chen, Li Wen

AU - Chen, Jiann Shiuh

AU - Tu, Yi Fang

AU - Wang, Shan Tair

AU - Wang, Lan Wan

AU - Tsai, Yi Shan

AU - Huang, Chao Ching

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Introduction Cyclosporine (CsA) is an immunosuppressant known for its neurotoxicity, which presents with acute encephalopathy and seizures in the most severe form. However, whether there is age-related neurological susceptibility in pediatric population is poorly defined. The study aims to examine the vulnerability of CsA neurotoxicity among different age groups of pediatric patients in terms of occurrence rate, acute presentations, long-term outcomes, and neuroimaging findings. Methods Pediatric patients (age

AB - Introduction Cyclosporine (CsA) is an immunosuppressant known for its neurotoxicity, which presents with acute encephalopathy and seizures in the most severe form. However, whether there is age-related neurological susceptibility in pediatric population is poorly defined. The study aims to examine the vulnerability of CsA neurotoxicity among different age groups of pediatric patients in terms of occurrence rate, acute presentations, long-term outcomes, and neuroimaging findings. Methods Pediatric patients (age

KW - Age factors

KW - Child

KW - Cyclosporine

KW - Neurotoxicity syndromes

KW - Seizures

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=84931575548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931575548&partnerID=8YFLogxK

U2 - 10.1016/j.ejpn.2015.02.003

DO - 10.1016/j.ejpn.2015.02.003

M3 - Article

C2 - 25769225

AN - SCOPUS:84931575548

VL - 19

SP - 464

EP - 471

JO - European Journal of Paediatric Neurology

JF - European Journal of Paediatric Neurology

SN - 1090-3798

IS - 4

ER -

Access to Document

10.1016/j.ejpn.2015.02.003